Matthew Bowen's most recent trade in Monte Rosa Therapeutics Inc was a trade of 13 shares done at an average price of $10.5 . Disclosure was reported to the exchange on Oct. 5, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Monte Rosa Therapeutics Inc | Mr. Matthew Bowen | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 10.54 per share. | 05 Oct 2026 | 13 | 25,891 | - | 10.5 | 137 | - |
| Monte Rosa Therapeutics Inc | Mr. Matthew Bowen | Principal Accounting Officer | 06 Apr 2026 | 19,500 | 19,500 | - | - | Stock Option (Right to Buy) | ||
| Monte Rosa Therapeutics Inc | Mr. Matthew Bowen | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Apr 2026 | 4,300 | 25,904 | - | - | Common Stock |